ArticleFrontiers in immunology2022

Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation.

Elena Díaz-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.